Sendero Wealth Management’s Boston Scientific BSX Stock Holding History

Sendero Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479K	Sell	11,219 -86	-0.8%	-$4.67K	0.05%	162
2026 Q1	$709K	Buy	+11,305	New	+$904K	0.08%	136
2024 Q2	–	Sell	-35,767	Closed	-$2.45M	–	158
2024 Q1	$2.45M	Sell	35,767 -506	-1%	-$32.5K	0.42%	50
2023 Q4	$2.1M	Sell	36,273 -9	-0%	-$480	0.4%	51
2023 Q3	$1.92M	Buy	36,282 +1,817	+5%	+$95.3K	0.41%	50
2023 Q2	$1.86M	Sell	34,465 -17,333	-33%	-$905K	0.41%	52
2023 Q1	$2.59M	Sell	51,798 -7,059	-12%	-$333K	0.79%	27
2022 Q4	$2.72M	Buy	58,857 +713	+1%	+$30.9K	0.97%	14
2022 Q3	$2.25M	Buy	58,144 +3,240	+6%	+$130K	0.94%	14
2022 Q2	$2.05M	Buy	+54,904	New	+$2.23M	1.96%	9
2022 Q1	–	Sell	-30,881	Closed	-$1.31M	–	81
2021 Q4	$1.31M	Buy	+30,881	New	+$1.3M	0.58%	29

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sendero Wealth Management's BSX Position: Q2 2026 in Review

Sendero Wealth Management reduced its Boston Scientific (BSX) stake by 0.76% in Q2 2026, selling an estimated $4.67K and leaving 11,219 shares worth $479K. The position accounts for 0.05% of the portfolio, ranked #162.

Sendero Wealth Management first reported a position in BSX in Q4 2021 and has held it in 11 quarters since. The position peaked at $2.72M in Q4 2022. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sendero Wealth Management held 11,219 shares of Boston Scientific worth $479K as of Q2 2026.
Sendero Wealth Management sold 86 Boston Scientific shares in Q2 2026, an estimated $4.67K.
Boston Scientific made up 0.05% of Sendero Wealth Management's portfolio in Q2 2026, its #162 holding.
Sendero Wealth Management first reported a position in Boston Scientific in Q4 2021 and has held it in 11 quarters since.
Sendero Wealth Management's Boston Scientific position peaked at $2.72M in Q4 2022.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sendero Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.